Minimum System Requirements
Operating System:
Windows®: Microsoft Windows® 2000 and Windows® XP
Macintosh®: Mac OSX
Memory:
256 MB of available RAM
Processor:
500mhz processor
Software:
Macromedia® Flash Player 8.0 and higher
Adobe Acrobat Reader® 6.0 and higher
Internet Browser:
Any of the following:
Internet Explorer® 6.0 and above,
Netscape® 7.0 and above,
FireFox® 1.5 and above,
Safari™ 2.0 and above
For technical assistance with this site, please contact John Long with EyeWorld Newsmagazine at john@eyeworld.org or (703) 591-2220 8:00 AM to 5:00 PM Eastern.
Continuing Medical Education (CME)
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians. ASCRS takes responsibility for the content, quality, and scientific integrity for these activities.
CME Credits
ASCRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Each physician should claim credit commensurate with the extent of their participation in the activity. Please note physicians must check in at the symposium registration desk onsite to be eligible for credit.
Claiming CME Credit
Participants must take the online test once they have completed their review of all material within this supplement. A hard copy of the supplement was mailed to ophthalmologists with
EyeWorld Newsmagazine, Volume 12, Issue 9 – September, 2007. An electronic version of the supplement is available for online viewing or download through the link at the bottom of this page.
An online post-activity test has been created from the supplement material. To receive CME credit 80% of the questions must be answered correctly. The test must be completed individually and answers based on personal knowledge gained from reviewing the written material.
Once the test has been completed with a score of 80% or higher, a CME certificate will be available to print using the browser’s print function.
Participants who receive a score of less than 80% will have the opportunity to review the material and take the test again.
ASCRS will keep the earned CME information on file for the required time.
Expiration Date
CME credit for this educational activity is valid through March 15, 2008. CME credit will not be awarded after that date.
CME Questions?
Please contact Laura Johnson with the American Society of Cataract and Refractive Surgery at ljohnson@ascrs.org or (703) 591-2220 8:00 AM – 5:00 PM Eastern if you have any questions regarding CME credit for this educational activity.
Target Audience
This educational activity is intended for ophthalmologists with an interest in the anterior segment.
Educational Objectives
Ophthalmologists who take part in this educational activity will be able to:
- Discuss and evaluate the use of topical and intracameral antibiotics and NSAIDs in cataract surgery
- Integrate pearls for handling IFIS during cataract surgery, and
- Develop treatment regimens that improve patient outcomes
Faculty Credentials
Eric D. Donnenfeld, MD, Moderator
Co-Chairman, Cornea & External Disease, Manhattan Eye, Ear and Throat Hospital
Rockville Center, New York
David F. Chang, MD
Clinical Professor of Ophthalmology, University of California, San Francisco
San Francisco, California
Louis D. Nichamin, MD
Medical Director, Laurel Eye Clinic, Brookville, Pennsylvania
Brookville, Pennsylvania
Calvin W. Roberts, MD
Clinical Professor of Ophthalmology, Weill Medical College of Cornell University
New York, New York
Financial Interest Disclosure
As a sponsor accredited by the Accreditation Council on Continuing Medical Education, ASCRS•ASOA must ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly sponsored activities.
All individuals participating in a ASCRS-sponsored CME activity must disclose any financial interest or relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation or lack thereof. Financial interest can include such things as grants or research support, employee, consultant, major stockholder, member of speakers bureau, etc.
The intent of this disclosure is not to prevent participants with a significant financial or other relationship from presenting, but rather to provide the Program Committee with information so they can design and implement a balanced, independent, and scientific educational activity. The Financial Interest Index within the sponsored activity’s Final Program provides information to attendees so they can make their own judgment regarding the interest or relationship and the materials presented.
Category |
Code |
Specific Financial Interest |
Product |
P |
I earn royalty or derive other financial gain from an ophthalmic product or service. |
Investor |
R |
I have a significant investment interest in a company that makes/develops/provides ophthalmic products or services. |
Consultant |
A |
I receive a retainer, ad hoc fees, or other consulting income from a company that makes/develops/provides ophthalmic products or services. |
| |
B |
I am a member of the speaker's bureau of a company that makes/develops/provides ophthalmic products or services. |
| |
C |
I provide practice management or marketing consulting services to ophthalmic practices. |
Research |
D |
My research is fully or partially funded by a company that makes/develops/provides ophthalmic products or services. |
Travel |
E |
My travel expenses have been reimbursed, paid in full or subsidized, by a company that makes/develops/provides ophthalmic products or services. |
None |
N |
I have no financial interest in any company that makes/develops/provides ophthalmic products or services. |
David F. Chang, MD
Advanced Medical Optics A
Alcon Laboratories A
Calhoun Vision Inc R
Cataract & Refractive Surgery Today A
Ista Pharmaceuticals Inc. E
Peak Surgical A
Slack Inc. P
Visiogen Inc. A
Eric D. Donnenfeld, MD
Advanced Medical Optics A, B
Louis D. Nichamin, MD
3-D Vision Systems A, R
Advanced Medical Optics A
Allergan Inc. A
Bausch & Lomb A
eyeonics Inc. A
Glaukos Corporation A
Medtronic Ophthalmics B
PowerVision A, R
Refractec A
Calvin W. Roberts, MD
None N
Notice About Off-Label Use Presentations
This EyeWorld Educational Symposium Supplement may include presentations on drugs or devices, or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.
ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.
ADA/Special Accommodations
ASCRS fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any participant in this online educational program who requires special accommodation or services should contact John Long at john@eyeworld.org of (703) 591-2220 8:00 AM – 5:00 PM Eastern.
View Supplement Online
Download Supplement PDF
Post-Activity Test
By taking this online CME test, I certify that I am a physician licensed to practice and that my answers have been completed individually and are based on personal knowledge gains from review of the noted material.
I understand I must answer 80% of the questions correctly to receive credit. If I do not answer at least 80% of the questions correctly, I will have the opportunity to review the material and take the test again.